The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.
Bernhard ScheinerPatrick G NorthupAnselm B GruberGeorg SemmlerGerda LeitnerPeter QuehenbergerJohannes ThalerCihan AyMichael TraunerThomas ReibergerJ P LuyendykMattias MandorferPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Although non-O-BT impacts VWF in patients with early stage ACLD, its contribution to VWF variation is considerably smaller than in the general population. Moreover, non-O-BT had no impact on FVIII. These findings may explain the absence of an association between non-O-BT and PVT in patients with advanced cirrhosis.